Pharmaceutical Industry discussion, review, analysis, news and information. |
« Bayer Schering Pharma AG’s Oral Fludara®, Approved in Japan | Main | Berlex, Inc.’s YAZ®, USFDA-Approved for New Indication: Treatment of Acne »
|
Jan29
|
Copegus® (pdf file) is an antiviral agent developed by F. Hoffmann-La Roche or ROCHE (OTC: RHHBY, VTX: ROG) [Head Office: Basel, Switzerland]. Find more details from the press release. |
TrackBack URL for this entry:
« Bayer Schering Pharma AG’s Oral Fludara®, Approved in Japan | Main | Berlex, Inc.’s YAZ®, USFDA-Approved for New Indication: Treatment of Acne »
Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!
BIZZlogos - Add your logo - free link to your site| View Network Map Network Feed List (OPML) Know More Media Network Feed |
PharmaGazette is a member of the Know More Media network of business related blogs.
Here are some current headlines from some of our business publications:
ProductivityGoal | CallCenterScript |
AdHurl | TheBizofKnowledge |
LandingTheDeal | CustomersAreAlways |
HealthCareVox | BrainBasedBusiness |
TheInsurancePolicy | MarketingBlurb |
Write for us About us Contact Advertise Privacy Disclaimer
This weblog is licensed under a Creative Commons License.
Comment Preview